Journal article · 2024 · Open access
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Alzheimer s & Dementia, 20(8), 5143–5169 · Published 27 June 2024 · DOI 10.1002/alz.13859
In brief
“Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup” is a 2024 journal article by Clifford R. Jack and 19 co-authors, published in Alzheimer s & Dementia. OpenAlex counts 3,152 citations as of 15 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Alzheimer s & Dementia.
- Citations
- 3,152
- Most cited in
- 2026 (1,675)
- Field-weighted impact
- 709.19
- References
- 245
- Authors
- 20
Abstract
The National Institute on Aging and the Alzheimer's Association convened three separate work groups in 2011 and single work groups in 2012 and 2018 to create recommendations for the diagnosis and characterization of Alzheimer's disease (AD). The present document updates the 2018 research framework in response to several recent developments. Defining diseases biologically, rather than based on syndromic presentation, has long been standard in many areas of medicine (e.g., oncology), and is becoming a unifying concept common to all neurodegenerative diseases, not just AD. The present document is consistent with this principle. Our intent is to present objective criteria for diagnosis and staging AD, incorporating recent advances in biomarkers, to serve as a bridge between research and clinical care. These criteria are not intended to provide step-by-step clinical practice guidelines for clinical workflow or specific treatment protocols, but rather serve as general principles to inform diagnosis and staging of AD that reflect current science. HIGHLIGHTS: We define Alzheimer's disease (AD) to be a biological process that begins with the appearance of AD neuropathologic change (ADNPC) while people are asymptomatic. Progression of the neuropathologic burden leads to the later appearance and progression of clinical symptoms. Early-changing Core 1 biomarkers (amyloid positron emission tomography [PET], approved cerebrospinal fluid biomarkers, and accurate plasma biomarkers [especially phosphorylated tau 217]) map onto either the amyloid beta or AD tauopathy pathway; however, these reflect the presence of ADNPC more generally (i.e., both neuritic plaques and tangles). An abnormal Core 1 biomarker result is sufficient to establish a diagnosis of AD and to inform clinical decision making throughout the disease continuum. Later-changing Core 2 biomarkers (biofluid and tau PET) can provide prognostic information, and when abnormal, will increase confidence that AD is contributing to symptoms. An integrated biological and clinical staging scheme is described that accommodates the fact that common copathologies, cognitive reserve, and resistance may modify relationships between clinical and biological AD stages.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W. J., McDade, E., Molinuevo, J. L., Okonkwo, O. C., Pani, L., Rafii, M. S., Scheltens, P., Siemers, E., Snyder, H. M., Sperling, R. A., Teunissen, C. E., & Carrillo, M. C. (2024). Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer s & Dementia, 20(8), 5143–5169. https://doi.org/10.1002/alz.13859
MLA 9
Jack, Clifford R., et al. “Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.” Alzheimer s & Dementia, vol. 20, no. 8, 2024, pp. 5143–5169. https://doi.org/10.1002/alz.13859.
Chicago
Jack, Clifford R., Jeffrey Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, et al. 2024. “Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.” Alzheimer s & Dementia 20 (8): 5143–5169. https://doi.org/10.1002/alz.13859.
Harvard
Jack, C. R. et al. (2024) ‘Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup’, Alzheimer s & Dementia, 20(8), pp. 5143–5169. doi:10.1002/alz.13859.
IEEE
C. R. Jack et al., “Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup,” Alzheimer s & Dementia, vol. 20, no. 8, pp. 5143–5169, 2024, doi: 10.1002/alz.13859.
BibTeX
@article{jack2024revised,
title = {{Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup}},
author = {Jack, Clifford R. and Andrews, Jeffrey Scott and Beach, Thomas G. and Buracchio, Teresa and Dunn, Billy and Graf, Ana and Hansson, Oskar and Ho, Carole and Jagust, William J. and McDade, Eric and Molinuevo, José Luís and Okonkwo, Ozioma C. and Pani, Luca and Rafii, Michael S. and Scheltens, Philip and Siemers, Eric and Snyder, Heather M. and Sperling, Reisa Anne and Teunissen, Charlotte Elisabeth and Carrillo, María C.},
journal = {Alzheimer s \& Dementia},
year = {2024},
volume = {20},
number = {8},
pages = {5143--5169},
doi = {10.1002/alz.13859},
url = {https://doi.org/10.1002/alz.13859}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 218 | |
| 2025 | 1,258 | |
| 2026 | 1,675 |
Its field-weighted citation impact is 709.19: it has been cited 709.19 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- diagnostic criteria
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W. J., McDade, E., Molinuevo, J. L., Okonkwo, O. C., Pani, L., Rafii, M. S., Scheltens, P., Siemers, E., Snyder, H. M., Sperling, R. A., Teunissen, C. E., & Carrillo, M. C. (2024). Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer s & Dementia, 20(8), 5143–5169. https://doi.org/10.1002/alz.13859
How many times has this paper been cited?
3,152 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Alzheimer s & Dementia.
Who wrote this paper?
Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, Carole Ho, William J. Jagust, Eric McDade, José Luís Molinuevo, Ozioma C. Okonkwo and 8 more.
What is the DOI of this paper?
10.1002/alz.13859. The permanent link is https://doi.org/10.1002/alz.13859.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.